Written and maintained by CASRAI Editorial Board
Last updated
Addgene is a non-profit plasmid repository and biological resource center that archives, sequence-verifies, and distributes recombinant DNA plasmids, viral vectors, and molecular biology reagents to researchers worldwide. Founded in 2004 and operating on a self-sustaining cost-recovery model, Addgene eliminates the logistical, legal, and quality-control bottlenecks that traditionally hindered peer-to-peer materials transfer between academic laboratories.
In modern life science and biomedical engineering research, rapid access to authenticated molecular constructs is critical for experimental reproducibility. Rather than requesting constructs directly from author laboratories—a process historically fraught with unverified plasmid sequences, stalled Material Transfer Agreements (MTAs), and transit delays—investigators rely on Addgene as a centralized distribution hub. Operating in alignment with institutional open-science policies and funding requirements like the NIH Resource Sharing Plan, the platform enables investigators to easily deposit published constructs and acquire verified genetic materials.
What it is
Addgene serves as an international public repository for plasmid DNA and viral preparations. A plasmid is an extrachromosomal circular DNA molecule widely engineered in molecular biology to express proteins, deliver RNA interference cassettes, or execute CRISPR-mediated genome editing. When scientists publish findings describing new genetic constructs, scientific journals and public grant agencies typically require that those materials be made accessible to the wider scientific community.
Addgene operates as a trusted intermediary between donating laboratories (depositors) and ordering laboratories (recipients). When an investigator deposits a plasmid, Addgene archives the bacterial stock, conducts rigorous quality control sequencing, digitizes associated plasmid metadata, and handles all legal agreements required for physical distribution. Recipients receive authenticated bacterial stabs or high-titer viral vectors ready for bench work, along with verified sequence maps, antibiotic resistance markers, and growth protocols.
Who runs it and what it covers
Addgene is operated by Addgene, Inc., an independent 501(c)(3) non-profit organization located at 490 Arsenal Way, Suite 100, Watertown, Massachusetts 02472, USA. Founded by Melina Fan, Kenneth Fan, and Benjie Chen, the organization was established to provide a reliable, long-term operational infrastructure for biological reagent sharing. Since 2007, Addgene has operated as a fully self-sustaining non-profit, covering operational costs through modest distribution fees rather than relying on continuous federal or philanthropic grant cycles.
The organization employs a multidisciplinary team of doctoral-level molecular biologists, quality control scientists, laboratory technicians, software engineers, and technology transfer professionals. The repository’s collection encompasses more than 140,000 unique plasmids contributed by thousands of laboratories across more than 500 research institutions globally. Major areas covered within the collection include:
- CRISPR and Genome Editing: More than 20,000 CRISPR-associated plasmids spanning Cas9, Cas12 nucleases, prime editors, base editors, and CRISPR interference/activation (CRISPRi/a) tools, distributed hundreds of thousands of times worldwide.
- Viral Vectors and Packaging Systems: Specialized packaging, envelope, and transfer plasmids for lentivirus, retrovirus, and adeno-associated virus (AAV) production, alongside ready-to-use, high-titer pooled and purified viral preparations.
- Synthetic Biology and Expression Vectors: Promoter libraries, fluorescent protein tags, epitope tagging systems, inducible expression switches, and standardized cloning backbones.
- Chemogenetics and Optogenetics: Channelrhodopsins, halorhodopsins, and designer receptors exclusively activated by designer drugs (DREADDs) utilized extensively in neurobiology and physiological research.
How to search or use it
Navigating Addgene involves standardized workflows for finding, ordering, or depositing biological materials. The primary operational steps are:
- Search the Addgene Vector Database: Use the primary search interface at addgene.org to query by gene name, gene symbol, protein alias, depositor Principal Investigator (PI), publication author, or specific Addgene accession number. Alternatively, utilize the “Search by Sequence” BLAST feature to match nucleotide or translated amino acid sequences against Addgene’s catalog.
- Examine the Plasmid Data Page: Every catalog entry features a dedicated Plasmid Data Page detailing the vector backbone, cloning sites, bacterial resistance markers (such as ampicillin or kanamycin), growth temperature, copy number, selectable mammalian markers, and a fully annotated plasmid map. Reviewing these specifications ensures compatibility with your downstream host system.
- Access or Create an Account: Navigate to the website login portal to access your institutional user profile. Account holders must register using their official institutional email address to allow proper linkage to their research organization.
- Configure Order Details: Add target plasmids to the cart and specify the designated Recipient Scientist and Principal Investigator. Institutional purchasing agents can assemble carts on behalf of laboratory investigators.
- Process the Material Transfer Agreement (MTA): Plasmids require legal clearance under a standardized biological agreement, most commonly the Uniform Biological Material Transfer Agreement (UBMTA), OpenMTA, or Industry MTA (IMTA). Addgene’s electronic MTA system routes the agreement directly to the Technology Transfer Office (TTO) of the recipient institution for electronic signature.
- Order Dispatch and Physical Logistics: Following TTO approval and payment processing, Addgene fulfills the order. Plasmids are typically shipped as viable bacterial stabs (agar cultures) at ambient room temperature, while viral preparations and pooled libraries ship on dry ice via expedited courier.
- Revive and Verify the Material: Upon arrival, inoculate selective liquid broth or streak the bacterial stab onto selective agar plates to obtain single colonies. Isolate plasmid DNA via standard plasmid preparation protocols and confirm the construct integrity through restriction digests or Sanger sequencing before experimental use.
- Deposit Laboratory Reagents: Depositing laboratories initiate submissions through the “Deposit Material” online portal, uploading vector sequence files and publication citations before shipping physical plasmid DNA or agar stabs to Watertown for archiving.
Strengths and limits
Addgene offers distinct operational advantages alongside several structural boundaries that researchers must take into account when planning projects.
Strengths
- Centralized Quality Control: Addgene validates every deposited plasmid using next-generation sequencing (NGS) and Sanger sequencing across cloning junctions, ensuring that published sequences match the distributed physical DNA.
- Streamlined Technology Transfer: The automated electronic MTA portal eliminates months of bilateral legal negotiations between university technology transfer offices.
- Resource Sharing Compliance: Depositing materials enables investigators to fulfill funding mandates, including NIH Resource Sharing and Data Management and Sharing requirements, while tracking community citations.
- Affordable Cost-Recovery Model: Distribution fees are significantly lower than commercial gene synthesis or custom de novo vector construction.
Limits
- Catalog Bound by Community Deposits: Addgene cannot distribute plasmids that have not been voluntarily deposited by author laboratories.
- Administrative Lead Time: Orders cannot ship until the recipient institution’s Technology Transfer Office formally signs the electronic MTA, which can introduce administrative delays depending on institutional responsiveness.
- Non-Commercial Licensing Restrictions: Plasmids distributed under standard academic MTAs (such as the UBMTA) are strictly restricted to non-commercial academic research; industrial or for-profit entities must negotiate commercial licensing or Industry MTAs.
Alternatives
When specific genetic constructs or biological materials are unavailable through Addgene, researchers rely on alternative public repositories and commercial sourcing platforms.
| Platform / Source | Operator & Location | Core Scope & Materials | Quality Control & Legal Terms | Optimal Use Case |
|---|---|---|---|---|
| Addgene | Non-profit 501(c)(3) (Watertown, MA, USA) | Published academic plasmids, AAV/lentiviral preps, pooled CRISPR libraries | Next-generation sequencing verification; electronic UBMTA and OpenMTA | Sourcing published molecular tools, CRISPR constructs, and functional expression vectors |
| DNASU Plasmid Repository | Biodesign Institute, Arizona State University (USA) | Over 300,000 plasmids, specialized in human and pathogen cDNA/ORF clones | Full-insert sequence verification; academic MTA framework | High-throughput protein expression, functional proteomics, and systematic ORF screens |
| ATCC (American Type Culture Collection) | Non-profit bioresource center (Manassas, VA, USA) | Authenticated mammalian cell lines, microbial strains, viruses, and genomic DNA | ISO 9001 and ISO/IEC 17025 accredited authentication; ATCC MTA | Standardized microbial control strains, cell line authentication, and reference cultures |
| BCCM/GeneCorner | Ghent University & Belgian Science Policy Office (Belgium) | Recombinant plasmids, cloning vectors, host strains, and genetic libraries | Curated academic quality standards; European biological material transfer agreements | European researchers seeking specialized cloning vectors, host strains, and genetic collections |
| Commercial Gene Synthesis | Commercial providers (e.g., GenScript, Twist Bioscience) | Custom de novo synthesized DNA constructs, expression vectors, and gene fragments | 100% sequence accuracy guarantee via NGS; commercial supply purchase agreement | Custom-designed sequences, novel mutations, or constructs never deposited in public repositories |
Frequently asked questions
What is Addgene used for?
Addgene is used by biomedical researchers to deposit and obtain published plasmid DNA, viral vectors, and molecular biology reagents. It provides a centralized, quality-controlled repository where scientists can search for plasmids cited in academic literature, execute electronic Material Transfer Agreements, and order verified physical samples for laboratory experiments.
How long do Addgene orders take?
Addgene orders typically process and ship within 1 to 3 business days once the recipient institution’s Technology Transfer Office (TTO) signs the electronic Material Transfer Agreement (MTA) and payment is confirmed. Domestic US shipments dispatched via overnight or two-day courier usually arrive within 1 to 2 business days after shipment. International deliveries generally take 2 to 5 business days, depending on destination customs clearance and local import permit processing.
How should researchers cite Addgene plasmids in publications?
Researchers citing materials obtained from Addgene should credit both the original depositing laboratory and Addgene in the materials and methods section of their publication. The standard citation format includes the plasmid name, the depositing investigator, the publication describing the plasmid, the Addgene catalog number, and the unique Research Resource Identifier (RRID), for example: “Plasmid pX was a gift from Dr. Jane Doe (Addgene plasmid # 12345; http://n2t.net/addgene:12345; RRID: Addgene_12345).”
What is the Addgene address and headquarters location?
Addgene headquarters is located at 490 Arsenal Way, Suite 100, Watertown, Massachusetts 02472, USA. While administrative, customer support, and wet-lab biological fulfillment operations are based at this Watertown facility, all material orders and deposit requests must be submitted electronically through the addgene.org web portal.
How does Addgene distribute lentivirus and viral vectors?
In addition to standard plasmid DNA stabs, Addgene produces and distributes ready-to-use, high-titer lentiviral and adeno-associated viral (AAV) vector preparations. These viral preps are quality-tested for physical titer and sterility and are shipped on dry ice to ensure viral particle stability. Ordering laboratories must meet biosafety level requirements (typically BSL-2 for lentiviral vectors) and adhere to institutional biosafety committee approvals.
Can for-profit or industrial researchers request materials from Addgene?
Yes, for-profit and commercial organizations can request many materials from Addgene. However, because standard academic UBMTA terms prohibit commercial use, industry orders are governed by an Industry Material Transfer Agreement (IMTA) or require direct commercial licensing from the depositing institution before fulfillment.
Where do researchers access the Addgene vector database, login, and sequence downloads?
Researchers can access the Addgene vector database directly at addgene.org by using the global search field to locate constructs. User account login and order tracking are available via the top-navigation sign-in portal. Sequence files—including GenBank (.gb) and SnapGene (.dna) formats—can be downloaded free of charge directly from any individual Plasmid Data Page without placing a physical order.
Sources
- Kamens, J. (2015). The Addgene repository: an international nonprofit plasmid and data resource. Nucleic Acids Research, 43(Database issue), D1152–D1157. https://doi.org/10.1093/nar/gku893 (Read 2026-11-07).
- Kamens, J. (2014). Addgene: making materials sharing “science as usual”. PLoS Biology, 12(11), e1001993. https://doi.org/10.1371/journal.pbio.1001993 (Read 2026-11-07).
- Addgene. (2026). Contact Addgene & Tech Transfer Overview. Addgene, Inc., Watertown, MA. https://www.addgene.org/contact/ and https://www.addgene.org/mta/ (Read 2026-11-07).
- Goren, A., et al. (2026). The Diversifying Distribution Trends of Maturing CRISPR Technologies by Addgene. The CRISPR Journal, 7(4). https://doi.org/10.1089/crispr.2024.0048 (Read 2026-11-07).







